Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.
11/10/2017
/
Publications
/
Toxicity
This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.
The study demonstrated PBT...
Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.
11/11/2017
/
Publications
/
Hypofractionation
A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...
Establishing evidence-based indications for proton therapy.
10/11/2016
/
Publications
/
Clinical Trial
PT101
An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...
Biochemical Results, Toxicity, Patient QoL After Delivery of Dose-Escalated Image Guided PT for Prostate Cancer
01/02/2016
/
Publications
/
Toxicity
A large series of 1327 localized prostate cancer patients reported 5-year biochemical control rate, toxicity and patient-reported quality of life after proton...
PBT in rectal cancer
28/07/2021
/
Publications
/
Clinical Trial
PT101
This review article examined eight original studies with a total of 127 patients. There was significantly less irradiated small bowel with PBT compared to 3DCRT...
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
28/09/2021
/
Publications
A study by the Mayo Clinic group. This study examined the acute CTCAE reported by 55 patients (PRO-CTCAE) with high-risk or unfavorable intermediate-risk...
Is Proton Therapy for Prostate "Experimental"?
19/01/2022
/
Podcast
In this podcast we discuss the role of proton therapy for prostate cancer. It has been referred to as "experimental", but is showing to be increasingly...
Prostate Cancer
24/02/2023
/
Webinar
Jason Efstathiou gives an overview of protons for prostate cancer. He covers the clinical potential, the available and comparative data, and the future...
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
29/04/2024
/
Publications
/
IMRT
This study compared the bowel function (BF), urinary irritative/obstructive symptoms (UO), and urinary incontinence (UI) domains of EPIC-26 collected in 262...
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
06/05/2024
/
Publications
/
Toxicity
Published in the Green Journal, this systematic review analyzed 160 studies of hypofractionated PT (n=11) or XRT (n=148) or PT+XRT (n=1) for localized prostate...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.